"FactView Malaria Rapid PF/PV" likely refers to a diagnostic test for the rapid detection of Plasmodium falciparum (PF) and Plasmodium vivax (PV), two species of malaria parasites. Here's more information about this type of diagnostic test:
Purpose: The FactView Malaria Rapid PF/PV test is used for the rapid detection of malaria infection caused by the Plasmodium falciparum and Plasmodium vivax parasites. Malaria is a serious infectious disease transmitted by the bite of infected Anopheles mosquitoes.
Principle: The test is based on immunochromatographic principles, where specific antibodies are used to detect the presence of malaria antigens in a patient's blood sample. The presence of the PfHRP2 antigen indicates P. falciparum infection, while the presence of the pLDH antigen indicates P. vivax infection.
Components: The FactView Malaria Rapid PF/PV test typically includes test cassettes, sample droppers, buffer solutions, and desiccants. The test cassettes contain pre-coated membranes with specific antibodies for detecting malaria antigens.
Procedure: The test procedure involves collecting a small amount of blood from the patient (usually obtained via finger prick) and applying it to the sample well of the test cassette. Buffer solution is then added, allowing the blood sample to migrate along the test strip. Results are typically visible within 15-20 minutes.
Interpretation: The appearance of colored lines on the test strip indicates the presence or absence of malaria antigens. A visible line in the control region indicates that the test is valid. Additional lines in the test regions indicate positive results for P. falciparum and/or P. vivax antigens.
Sensitivity and Specificity: The FactView Malaria Rapid PF/PV test demonstrates high sensitivity and specificity for detecting malaria infections caused by P. falciparum and P. vivax parasites. However, like all diagnostic tests, false-positive and false-negative results are possible and should be interpreted in conjunction with clinical findings.
Utility: Rapid diagnostic tests like the FactView Malaria Rapid PF/PV provide a quick and convenient method for diagnosing malaria infections in resource-limited settings, where access to laboratory facilities and microscopy may be limited.
Limitations: While rapid diagnostic tests are valuable tools for malaria diagnosis, they have limitations compared to more sensitive methods such as microscopy or molecular testing. Factors such as test storage conditions, operator technique, and the stage of infection can influence test performance.
A rapid test for the qualitative detection of circulating antigens of Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae in whole blood. For professional in vitro diagnostic use only. Sensitivity The Malaria P.f/ Pan Rapid Test Device (Whole Blood) has been tested with thin or thick microscopy on clinical samples. The results show that the sensitivity of the Malaria P.f/ Pan Rapid Test Device (Whole Blood) is >99.9% relative to microscopy. For Pan: Relative Sensitivity: >99.9% (158/158) (97.6%100.0%)* For P.f: Relative Sensitivity: >99.9% (53/53) (93%100.0%)* Specificity The Malaria P.f/ Pan Rapid Test Device (Whole Blood) uses highly specific antibodies for Malaria P.f/ Pan antigens in whole blood. The results show that the specificity of the Malaria P.f/ Pan. Rapid Test Device (Whole Blood) is over 99.0% relative to microscopy. Relative Specificity: >99.0% (324/327)(97.3%99.8%)* Accuracy: >99.4%(535/538)(98.3%99.8%)* * 95% Confidence Interval Total Results211327538 Note: The comparison for Pan line has been only done with blood specimens positive with Plasmodium vivax specimen. The claims for Pan lines are based on scientific findings that Pan-malarial Aldolase is found in other malarial parasites including Plasmodium ovale and Plasmodium malariae.
Supplier: Rapid detection kit, ribonucleic acid detection reagent, medical syringes, medical mask, medical ventilator, medical glove, medical isolation gown, surgical gown level 3+4, protective gown (overall ), oximeter, other medical products
For in vitro qualitative detect of Covid-19 antigen in nasal(NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days of the onset of the symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, and not for at home testing. 1.Easy to collect samples simple operation without professional equipment. 2.The test results are available in 15 minutes, and the test results are clearly visible. 3.Convenient transportation and low price, higher accuracy. 4.Suitable for large-scale rapid screening. Shelf life: 24 Months Test Result time: 10 Mins Packing: 25 Pieces per Box
a) WHO certified kit b) CE Certified Kit THE ABOVE GIVEN PRICE IS EX-FACTORY VAPI WARE HOUSE